Gastritis | Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis
Gastritis research study
What is the primary objective of this study?
The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription Weiqi decoction on Chronic Atrophic Gastritis.
Who is eligible to participate?
Inclusion Criteria: - Clinical diagnosis of Chronic Atrophic Gastritis - Male of female patients between 18-65 years old - Written informed consent Exclusion Criteria: - Combine with malignant pathology on epithelial dysplasia of gastric mucosa - Combine with duodenal ulcer or gastric ulcer - Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease. - Pregnancy or breast feeding women, or unwilling to have contraception.
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Drug:Weiqi decotionDecoction ,two times a day
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
low dose of Weiqi decoction
Start Date: August 2009
Completed Date: July 2012
Primary Outcome: Symptoms and conditions of tongue and pulse,the gastroscopy and pathological change
Secondary Outcome: Indicates of liver and renal function
Study sponsors, principal investigator, and references
Principal Investigator: Xie Jianqun, Phd
Lead Sponsor: Shanghai University of Traditional Chinese Medicine